Find latest Myeloma videos
·
200+ videos
Speed-Meet the Multidisciplinary Team: Hematologist
By
Springer Healthcare IME
FEATURING
Paolo Milani
By
Springer Healthcare IME
FEATURING
Paolo Milani
Dr Roberta Mussinelli, part of the multidisciplinary team in the Amyloidosis Research and Treatment Center, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy, talks about the effective collaboration that focuses on diagnosis and treatment of systemic amyloidosis.
Amyloidosis is a complex disease encompassing various subtypes. It places a significant burden on patients and healthcare systems worldwide.
Delayed diagnoses are common, and patients can face a grim prognosis with the risk of death within 3 months to 15 years without treatment, depending on the subtype of amyloidosis.
To learn more about the full program, visit pbc.ime.springerhealthcare.com
---
AstraZeneca and Alexion, AstraZeneca Rare Disease have provided an unrestricted educational grant towards this independent program.
Delayed diagnoses are common, and patients can face a grim prognosis with the risk of death within 3 months to 15 years without treatment, depending on the subtype of amyloidosis.
Amyloidosis is a complex disease encompassing various subtypes. It places a significant burden on patients and healthcare systems worldwide.
Delayed diagnoses are common, and patients can face a grim prognosis with the risk of death within 3 months to 15 years without treatment, depending on the subtype of amyloidosis.
To learn more about the full program, visit pbc.ime.springerhealthcare.com
---
AstraZeneca and Alexion, AstraZeneca Rare Disease have provided an unrestricted educational grant towards this independent program.
Delayed diagnoses are common, and patients can face a grim prognosis with the risk of death within 3 months to 15 years without treatment, depending on the subtype of amyloidosis.
Comments 0
Login to view comments.
Click here to Login
